Clinical trial · Observational
Non Interventional German Leptomeningeal Disease Register
Deutsches Meningeosis Neoplastica Register
NCT06146010CI-TRIAL-00107581recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The planned multicenter register is intended to create a database in the form of a cancer register on the incidence and course of disease in Germany of leptomeningeal disease, the therapeutic measures administered in the real world and the complications.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leptomeningeal Disease | Leptomeningeal Neoplasm | ALIAS | 0.90 |
| Meningeal Neoplasms | Meningeal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- german leptomeningeal disease register
- description
- The aim of the leptomeningeal disease register is to establish an internet-based cancer register in which patients with leptomeningeal disease are recorded at the time of diagnosis and after appropriate information and consent to data collection. Due to the rapid progression of the disease and potential rapid deterioration, inclusion must take place at the time of diagnosis. The course of the disease in individual patients is then documented retrospectively on the basis of routine clinical care data for the entire duration of the study or until the death of the participating patients.
- interventionNames
- Other: No intervention
Primary outcomes (2)
- measure
- Progression-free survival depending on the treatment modalities
- timeFrame
- through study completion, an average of 1 year
- description
- Only descriptive analyses are planned for the data documented in the register. Absolute and percentage frequencies including two-sided 95% confidence intervals are determined for the frequency of use of certain treatment regimens.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with leptomeningeal disease * Written consent of the patient or legal guardian. * Capacity to give consent or legal guardianship * Age ≥ 18 years Exclusion Criteria: * Lack of informed consent from the patient * Lack of capacity to consent on the part of the person concerned or lack of legal guardianship * Age \< 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.